N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis

Article information

Korean J Intern Med. 2019;34(2):458-458

Publication date (electronic) : 2019 February 25

doi : https://doi.org/10.3904/kjim.2016.329.e1

Hae-Rim Kim ¹, Kyoung-Woon Kim ², Bo-Mi Kim ², Kyung-Ann Lee ¹, Sang-Heon Lee ¹

¹Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea

²Convergent Research Consortium for Immunologic Disease, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

This corrects the article "N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis" in Volume 34 on page 210.

Korean J Intern Med 2019;34:210-219

https://doi.org/10.3904/kjim.2016.329

In the article cited above, there was an error in the title. ‘N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis’ should be changed ‘N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis.’

We apologize for any inconvenience that this may have caused.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.